Nasdaq Cdmo News Today

Avid Bioservices (NASDAQ:CDMO – Get Free Report) had its target price raised by Royal Bank of Canada from $7.00 to $8.00 in a research note issued on Tuesday, Benzinga reports. The firm presently has an “outperform” rating on the biopharmaceutical company’s stock. Royal Bank of Canada’s price objective indicates a potential upside of 3.90% from […]

Avid Bioservices (NASDAQ:CDMO – Get Free Report) had its price objective raised by equities researchers at Royal Bank of Canada from $7.00 to $8.00 in a note issued to investors on Tuesday, Benzinga reports. The firm presently has an “outperform” rating on the biopharmaceutical company’s stock. Royal Bank of Canada’s price target suggests a potential […]

-- Recorded Third Quarter Revenue of $33.8 Million -- -- Signed $41 Million in Net New Business Resulting in Record High Backlog of $206 Million -- --...

NEW YORK, March 23, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities...

Avid Bioservices, Inc. (NASDAQ:CDMO – Get Free Report) was the recipient of a large decrease in short interest in the month of January. As of January 31st, there was short interest totalling 5,230,000 shares, a decrease of 5.6% from the January 15th total of 5,540,000 shares. Based on an average daily volume of 1,450,000 shares, […]

Shares of Avid Bioservices, Inc. (NASDAQ:CDMO – Get Free Report) have been given a consensus recommendation of “Moderate Buy” by the five brokerages that are presently covering the firm, MarketBeat.com reports. One investment analyst has rated the stock with a hold recommendation and four have issued a buy recommendation on the company. The average 12-month […]

Avid Bioservices, Inc. (NASDAQ:CDMO – Get Free Report) Director Richard B. Hancock purchased 23,000 shares of the stock in a transaction on Friday, December 15th. The stock was acquired at an average price of $5.86 per share, with a total value of $134,780.00. Following the acquisition, the director now directly owns 78,760 shares in the […]

Legato Capital Management LLC lowered its stake in shares of Avid Bioservices, Inc. (NASDAQ:CDMO – Free Report) by 20.4% in the third quarter, according to its most recent disclosure with the SEC. The fund owned 219,672 shares of the biopharmaceutical company’s stock after selling 56,137 shares during the period. Legato Capital Management LLC owned approximately […]

Avid Bioservices (NASDAQ:CDMO – Free Report) had its target price cut by Royal Bank of Canada from $15.00 to $7.00 in a research report released on Friday, Benzinga reports. They currently have an outperform rating on the biopharmaceutical company’s stock. A number of other brokerages also recently weighed in on CDMO. TheStreet downgraded shares of […]

Avid Bioservices (NASDAQ:CDMO – Get Free Report) and TetraLogic Pharmaceuticals (OTCMKTS:TLOG – Get Free Report) are both medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their earnings, analyst recommendations, institutional ownership, dividends, risk, valuation and profitability. Insider & Institutional Ownership 0.0% of TetraLogic Pharmaceuticals […]